IL10 and myeloid sarcoma: Conversely, impaired IL-10 expression may sustain neuroinflammation, as the decreased expression of IL-10 mRNA has been reported in MS patients, and reduced levels of IL-10 have been associated with clinical activity and disease progression [32].